Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-16Clinical Trial Update: A Study of Tarceva (Erlotinib) in Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Cancer Who Present Epidermal Growth Factor Receptor Mutations [Phase 2]
Phase 2 clinical trial update evaluating Tarceva (erlotinib) in patients with locally advanced, metastatic, or recurrent non-small cell lung…
-
FDA approval · 2015-11-13FDA Approved: TAGRISSO — Original Application (AstraZeneca Pharmaceuticals LP)
The FDA approved Tagrisso (osimertinib) in an Original Application for metastatic EGFR T790M mutation-positive non-small cell lung cancer af…
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy [Phase 2]
A Phase 2 trial evaluating individualized radiation dose escalation in Stage III non-small cell lung cancer using modern chemoradiotherapy w…
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. [NA]
Continuation study of sunitinib malate for patients who left a prior sunitinib trial; completed with results posted in 2015.
-
CLINICAL_TRIALS research · 2015-11-06Clinical Trial Update: Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery [NA]
A clinical trial evaluating palliative care for quality of life and symptom control in stage IIIB or stage IV non-small cell lung cancer tha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 study of ganetespib plus docetaxel in advanced non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: A Retrospective, Non-interventional, Multicenter, Observational Chart Review Study to Explore the Clinical Benefits of Retreatment With TKI in the Real World.
AstraZeneca-sponsored, multicenter retrospective chart review evaluating the potential clinical benefits of retreating EGFR-mutated non-smal…
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating the combination of radiation therapy with cisplatin and etoposide in unresectable non-small cell lung cancer; the s…
-
CLINICAL_TRIALS research · 2015-10-30Clinical Trial Update: Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo [NA]
This clinical trial update discusses evaluating FLT-PET and diffusion-weighted MRI for non-small cell lung cancer patients treated with a pl…
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER) [Phase 2]
Phase 2 study of Tarceva (Erlotinib) in locally advanced or metastatic non-squamous non-small cell lung cancer completed; results posted in …
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer
This update reports results from an observational study of Tarceva (erlotinib) in elderly patients with advanced non-small cell lung cancer;…
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302） [Phase 2]
Phase II trial of Anlotinib in patients with advanced non-small cell lung cancer (ALTER0302) has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating gemcitabine with platinum-based chemotherapy, with or without cetuximab, as first-line treatment fo…
-
CLINICAL_TRIALS research · 2015-10-28Clinical Trial Update: An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma [Phase 1]
A Phase 1 exploratory pharmacogenomic study evaluating cetuximab (Erbitux) as monotherapy in patients with metastatic non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer [Phase 1]
This is a Phase I trial assessing the safety and preliminary activity of combining cetuximab with gefitinib in patients with advanced or met…
-
CLINICAL_TRIALS withdrawal · 2015-10-28Clinical Trial Update: A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel [Phase 2]
A Phase 2 clinical trial evaluating whether EGFR status by FISH can predict response to cetuximab, carboplatin, and paclitaxel in non-small …
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
A SWOG-led clinical trial update on carcinogen exposure in lung tissue from smokers and non-smokers with newly diagnosed stage I-III non-sma…
-
CLINICAL_TRIALS research · 2015-10-23Clinical Trial Update: Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC [Phase 2]
This update reports a Phase 2 study evaluating stereotactic ablative radiotherapy for elderly patients with Stage I non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 randomized study comparing veliparib in combination with carboplatin and paclitaxel versus placebo in combination with carboplatin…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
This update reports results from a Phase 1/2 study evaluating the combination of dasatinib and erlotinib in non-small cell lung cancer. Resu…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/Phase 2 study of Tecemotide (L-BLP25) in participants with stage III unresectable …
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Computed Tomography (CT) Perfusion Imaging of Lung Cancer [NA]
A clinical trial evaluating CT perfusion imaging in non-small cell lung cancer was terminated; no results are provided in the update.
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors [Phase 1]
Phase Ib expansion study of intravenous CUDC-101 evaluating safety, efficacy, and pharmacokinetics in advanced head and neck, liver, breast,…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
This Phase 1 trial evaluated the safety and preliminary efficacy of combining pertuzumab with erlotinib in locally advanced or metastatic no…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Prophylactic Cranial Irradiation (PCI) Cognitive Tests in Non-small Cell Lung Cancer (NSCLC) Patients
Clinical trial update noting cognitive testing associated with prophylactic cranial irradiation in non-small cell lung cancer patients from …